Influence of peritoneal dialysis solutions with glucose and amino acids on ingestive behavior in rats. Continuous ambulatory peritoneal dialysis (CAPD) is often associated with malnutrition; reduced intake of nutrients due to anorexia is an important factor. The glucose load from glucosebased peritoneal dialysis (PD) solutions and amino acids from amino acid-based solutions may favor suppression of the appetite. To study this matter we used a new experimental model in free-moving, unstressed male Wistar rats (300 to 350 g) with feeding catheters channeled from the top of the skull to the oral cavity. When the rats recovered from surgery they were tested under standardized conditions by giving them an intraoral infusion (1 mI/mm) of a solution containing 342 glliter of the sucrose or 97 g/liter protein solutions while recording the time (volume) of ingestion. Control rats consumed 18.8 0.9 ml of the sucrose and 39.8 0.8 ml of the protein solutions. Injections of PD solutions with 13.6, 22.7 and 38.6 g/liter of glucose reduced the ingestion of sucrose by 12.4%, 23.6% and 36.1%, respectively, but did not affect the ingestion of protein. Injections of 30 ml of PD solutions containing 11, 18 and 31 g/liter of amino acids reduced the ingestion of both sucrose by 9.7%, 17.1% and 33.2% and of protein by 13.5%, 25.9% and 33.1%, respectively. We conclude that in our experimental model, the inhibition of appetite caused by peritoneal solutions containing glucose or amino acids seems to be specific for each nutritional constituent and not simply an effect of hyperosmolality or large filling volumes.
Influence of peritoneal dialysis solutions with glucose and amino acids on ingestive behavior in rats. Continuous ambulatory peritoneal dialysis (CAPD) is often associated with malnutrition; reduced intake of nutrients due to anorexia is an important factor. The glucose load from glucosebased peritoneal dialysis (PD) solutions and amino acids from amino acid-based solutions may favor suppression of the appetite. To study this matter we used a new experimental model in free-moving, unstressed male Wistar rats (300 to 350 g) with feeding catheters channeled from the top of the skull to the oral cavity. When the rats recovered from surgery they were tested under standardized conditions by giving them an intraoral infusion (1 mI/mm) of a solution containing 342 glliter of the sucrose or 97 g/liter protein solutions while recording the time (volume) of ingestion. Control rats consumed 18.8 0.9 ml of the sucrose and 39.8 0.8 ml of the protein solutions. Injections of PD solutions with 13.6, 22.7 and 38.6 g/liter of glucose reduced the ingestion of sucrose by 12.4%, 23.6% and 36.1%, respectively, but did not affect the ingestion of protein. Injections of 30 ml of PD solutions containing 11, 18 and 31 g/liter of amino acids reduced the ingestion of both sucrose by 9.7%, 17.1% and 33.2% and of protein by 13.5%, 25.9% and 33.1%, respectively. We conclude that in our experimental model, the inhibition of appetite caused by peritoneal solutions containing glucose or amino acids seems to be specific for each nutritional constituent and not simply an effect of hyperosmolality or large filling volumes.
A large proportion of patients treated with continuous ambulatory peritoneal dialysis (CAPD) show anthropometrie and biochemical signs of malnutrition [1] . The finding that requirements of protein in CAPD patients are higher than in healthy individuals [2, 31 , has been attributed, inter a/ia, to dialytic losses of protein and amino acids. The nutritional intakes of protein and energy are below the requirements [3-5J. Loss of appetite secondary to abdominal distension by the dialyzate, absorption of glucose or amino acids from the dialyzate and persistent uremic toxicity due to underdialysis have been thought to result in impairment of appetite [61. Moreover, several factors not directly linked to the dialytic treatment, such as psychosocial problems, medications, dietary restrictions and intercurrent illnesses, may partly account for the low nutritional intakes.
Glucose has been used as the primary osmotic agent since treatment with peritoneal dialysis was first started. Glucose, of course, is not an inert osmotic agent but is also a nutrient that can contribute as much as one third of the total energy intake, especially in patients with high peritoneal permeability [7] . There is, however, concern about the effects of chronic glucose exposure on the peritoneal membrane [81, and the potential contributory effect of glucose absorption to hyperglycemia, hyperinsulinemia, hyperlipidemia and obesity [9, 10] . To solve these problems, amino acids were introduced as alternative osmotic agents, and these may also compensate for protein and amino acid losses and for the inadequate intake of proteins [11] , On the other hand, amino acids absorbed from the dialysis fluid may inhibit the oral intake of nutrients, thereby minimizing the positive effect on nutrition of the amino acids absorbed; a similar effect may also be produced by glucose absorbed from glucose-containing dialysis fluids.
The influence of peritoneal dialysis solutions of varying composition and filling volumes on food intake was earlier examined in studies on rabbits [12] . These studies showed that amino acids and glucose have a non-specific inhibiting effect on food ingestion, depending on the osmolality of the solution, and that large filling volumes also inhibit food intake. However, no systematic studies have been done to determine whether peritoneal dialysis fluids that contain glucose or amino acids influence the oral intake of specific nutrients (carbohydrate and proteins).
In the present investigation, we employed a recently introduced experimental model for studies of the ingestive behavior in conscious, free-moving rats with feeding catheters channeled from the top of the skull to the oral cavity [13] . The aim of the investigation was to study in normal rats how various intraperitoneal (i.p.) filling volumes and various concentrations of glucose and amino acids in the peritoneal dialysis (PD) fluid influence the consumption of carbohydrate and protein solutions infused intraorally.
Methods
Operations lntraoral cannulae were implanted from the top of the skull to the oral cavity as described by Kaplan, Bender and Sodersten [13] .
The animals were allowed a post-operative recovery period of four weeks to overcome the metabolic effects of surgical trauma and allow infections which sometimes exist around the catheter to heal spontaneously. It is obviously important that the animals should be free of infections, since these reduce the food intake. Post-operative body wt was therefore recorded weekly and all the animals used for the experiment had regained preoperative weight by the time of the experiment.
Test of ingestive behavior
The pellets were removed at 07:00 hours and the animals were tested for protein or sucrose ingestion six hours later, that is, one hour after the lights were turned off. The pellets were replaced after testing. Intake was measured by placing each animal in a circular (35 cm in diameter) plexiglass arena. The rats had their intraoral cannulae connected to a peristaltic pump (Alitea XV, Ventur Alitea, Stockholm, Sweden) that delivers a solution containing a nutrient (sucrose or protein) at 1 ml/min. This activates ingestive behavior, which ends by the time the animal actively rejects the solution or passively lets it drip from its mouth [14] . The infusion was interrupted for 30 seconds and then started again. If the rat stopped ingesting either actively or passively within one minute after re-starting the infusion, the test was terminated. If not, the infusion was continued and again interrupted for 30 seconds when the animal rejected the solution. This procedure was repeated until the criterion, rejection of the solution within one minute after a 30 seconds interruption of the infusion, was fulfilled. Most rats stop ingesting the solution within the first minutes after having rejected it once. The rats were trained daily to ingest the intraoral diet solutions and the experiments were performed after a stable level of intake was attained. They were then studied once a day on consecutive days.
Intraoral diet solutions
Two different solutions were used, a carbohydrate solution containing sucrose 342 g (1 M)Iliter and a protein solution containing cascin 97 g/liter, representing the protein component of Fortimel® (Nutricia Nordica AB, Stockholm, Sweden), a solution used for enteral feeding. The solutions were prepared before each daily test.
Peritoneal dialysis solutions
Glucose-based peritoneal dialysis (PD) solutions contained 13.6, 22.7 and 38.6 g/liter anhydrous glucose (Dianeal®, Baxter, Castlebar, Ireland). The electrolyte concentrations were the same in the three solutions: sodium 132, calcium 1.75, magnesium 0.75, chloride 102 and lactate 35 mmol/liter. The osmolalities were 340, 390 and 480 mOsm/kg H20, respectively. Amino acid-based PD solutions containing 11.0, 18.4 and 31.2 g/liter of amino acids were prepared by diluting an amino acid solution for intravenous use (Renamin® Clintec Nutrition Co., affiliated with Baxter Healthcare Co. and Nestle S.A.) in a solution with the same electrolyte content as the glucose-based solution. The osmolalities of these solutions were 341, 376 and 436 mOsm/kg H20. A solution with the same electrolyte content but without glucose or amino acids was used as a control in the experiments made to test the effect of the PD solutions. The osmolality was 290 mOsm/kg H20.
Procedures
The PD solutions were given as intraperitoneal (i.p.) injections in a dose of 30 ml, except in the experiments in which the effect of the intraperitoneal filling volume was assessed. Twenty minutes after the i.p. injection, the intraoral infusion of the diet solution was started.
Effects of intraperitoneal filling volume on sucrose intake Eight rats with a stable intraoral sucrose intake were injected i.p. with 0, 10, 20, 30 and 40 ml of isotonic saline (0.9% NaCI) in random order on consecutive days and the amount of their intake of sucrose was then determined.
Effect of glucose-based PD solutions on intraoral sucrose or protein intake Two groups of rats, one with a stable intraoral sucrose intake (N = 8) and one with a stable intraoral protein intake (N = 8) were injected i.p. with 30 ml of control solution and solutions containing 13.6, 22.7 and 38.6 g/liter of glucose in random order and the amount of their intake of sucrose and protein, respectively, was determined.
Effect of amino acid-based PD solutions on intraoral sucrose or protein intake Two groups of rats, one with a stable intraoral sucrose intake (N = 8) and one with a stable protein intake (N = 8) were injected i.p. with 30 ml of control solution and solutions containing 11.0, 18.4 and 31.2 g/liter of amino acids in random order and the amount of their intake of sucrose and protein, respectively, was determined.
Duration of appetite suppression
In five rats with a stable intraoral intake of sucrose solution, sucrose ingestion was tested at different times after i.p. injection of 30 ml PD solution containing glucose (38.6 g/liter). The intraoral infusion of sucrose was started 30, 60, 120 and 180 minutes after the i.p. injection; the experiments were made on consecutive days in random order. Similarly, in another group of five rats with stable intraoral sucrose intake, the intake of sucrose was tested 30, 60, 120 and 180 minutes after i.p. injection of 30 ml solution containing amino acids (31.2 g/liter). Intake of sucrose solution without i.p. injection of PD fluid was used as control in each group.
Analysis of data Data are presented as mean 5EM and analyzed using one-way ANOVA followed by a paired t-test when the ANOVA test showed significance (P < 0.05).
Results

Adaptation of ingestive behavior
Rats receiving intraoral sucrose solution ingested relatively large amounts (13.5 0.8 ml) of the solution offered on the first day of the intraoral infusion, Then they increased their intake gradually before it stabilized at 18.8 0.9 ml on the fifth day (Fig.  1) . Rats receiving protein, on the other hand, had a low intake (2.8
Time, days Glucose concentration, g/liter Ingestion after injection of the glucose solutions were statistically compared with ingestion after injection of a control solution, which had the same electrolyte content but contained no glucose. < 0.05, (Fig. 3A) , corresponding to a reduction of 0.66, 1.31 and 2.87 g in sucrose intake. The protein ingestion was suppressed by 13.5%, 25.9% and 33.1%, respectively (Fig. 3B ), corresponding to a reduction of 0.52, 1.00 and 1.27 g in protein intake below the control level, that is, at each dose level the suppression of protein intake was higher than the dose of amino acids given i.p.
Duration of appetite suppression
The rats injected i.p. with 30 ml of PD solution containing glucose (38.6 g/liter) and tested for the subsequent intake of sucrose 30, 60, 120 and 180 minutes after i.p. injections had the lowest sucrose intake after 30 minutes after injection and then a gradual increase in intake over the following 150 minutes (Fig.   4A ).
The rats injected i.p. with 30 ml of solution containing amino acids (31.4 g/liter) and tested for the subsequent intake of sucrose Glucose concentration, g/liter 0.6 ml) on the first day of intraoral infusion and then increased their intake gradually over a longer period of time until it stabilized at 39.8 0.8 ml on the ninth day (Fig. 1) .
Influence of i.p. filling volume
Intraperitoneal injections of 0, 10, 20, 30 and 40 ml of isotonic saline (0.9%) had no effect on sucrose ingestion, as demonstrated in Table 1 , and they had no effect on protein ingestion (data not shown).
Intraperitoneal glucose-based PD solutions
Intraperitoneal injections of 30 ml of glucose-based PD solutions containing 13.6, 22.7 and 38.6 g/liter glucose provided a total i.p. dose of 0.41, 0.68 and 1.16 g glucose. The sucrose intake was suppressed in a dose-dependent manner by 12.2%, 23.6% and 36.1%, respectively ( Fig. 2A) , corresponding to a reduction in sucrose intake below the control level by 0.99, 2.58 and 3.74 g, that is, at each dose level the suppression of the sucrose intake was considerably higher than the dose of glucose given i.p. The glucose-based PD solutions had no significant effect on protein ingestion (Fig. 2B) . 18 31
Amino acid concentration, g/liter . The various doses of amino acids were in each group injected in random order on successive days. Ingestion after injection of the glucose solutions were statistically compared with ingestion after injection of a control solution, which had the same electrolyte content but contained no glucose. < 0.05, < 0.01, ***p < 0.001. 30 , 60, 120 and 180 minutes after i.p. injections, showed a reduction in sucrose intake 30 minutes after injection followed by a further decrese in intake over the following 150 minutes (Fig.   4B ).
Discussion In the present studies we assessed ingestive behavior quantitatively by measuring the consumption of orally infused nutritional solutions in conscious, free-moving rats. This model has earlier been used in neuropharmacological studies of appetite regulation and has proved to be accurate and highly reproducible, especially since the same group of animals can be studied repeatedly on consecutive days and can serve as their own controls [13, 14] . A training and adaptation period is required during which the intake of the orally infused solution is gradually increased until a stable intake level is attained. This adaptation period was considerably longer with the protein solution than with the sucrose solution (Fig. 1) .
Abdominal distension by the dialysis fluid in the peritoneal cavity has been thought to interfere with gastric emptying, possibly resulting in impairment of food intake [15, 16] . However, we found in this study no suppression of food intake with peritoneal filling volumes up to 40 ml, that is, more than 10 per cent of the body wt of the rats. In accord with this, Hylander et a! found no difference in intragastric pressure [17] , and no difference in the consumption of a standard meal in CAPD patients with and without dialyzate [18] . Balaskas, Rodela and Oreopoulos [12] , on the other hand, reported that the food intake was significantly suppressed by large filling volumes (10% of the body wt) in rabbits studied over two to four weeks and that the effect was more marked when the total osmolality was high. In rabbits receiving four daily exchanges of dialysis solution (5% of body wt) containing either amino acids (2%) or glucose (1.5%), they also observed that the food intake was similarly depressed by both solutions, but it gradually returned towards control levels at the end of a six-week period. The experiments by Balaskas et al differed from
our acute experiments in several respects: they extended over several weeks, required surgical peritoneal catheter placement, involved metabolic adaptation to the surgical trauma and were performed in a different species.
Our results demonstrate that both glucose and amino acidcontaining peritoneal solutions have a dose-related inhibiting effect on the oral intake of sucrose. However, in contrast to the amino acid solutions the glucose solution did not suppress the intake of protein. This seems to rule out the view that the inhibition of appetite was a nonspecific effect of the high osmolality since, if this had been so, the glucose solutions might have been expected to inhibit the oral intake not only of sucrose but also of protein.
Considerable emphasis has been placed on the regulation of food intake by circulating nutrients [19] . It is generally assumed that there are various types of cells which sense the presence of specific nutrients or respond to their rate of metabolism or production of specific metabolites and that these cells are capable of signaling this information to the region of the brain that controls food intake [191. In addition, hormonal signals generated by the gastrointestinal tract are sensed directly by the brain so that changes in appetite and food intake occur. Thus, satiety is a result of elevated levels of specific circulating nutrients and gastrointestinal signals [19] .
It has been reported that intraportal or intramesenteric infusion of glucose suppresses feeding in fasting animals [20, 21] , probably because of signaling by hepatic glucoreceptors via the vagus nerve.
Moreover, elevated glucose levels cause an increase in plasma insulin, which terminates feeding via insulin-sensitive cells in the brain [22] . Our data showing that intraperitoneal glucose elicits dose-dependent reduction of carbohydrate ingestion are in accordance with previous reports.
In the cascade of gastrointestinal secretions following a meal, the sulfated cholecystokinin octapeptide (CCK-8) is a physiological satiety signal in the rat [23] . Recent studies by our group demonstrate that CCK-8 inhibits the intake of carbohydrate, but not protein [24, 25] . Our results, showing an inhibiting effect of i.p. glucose on carbohydrate, but not on protein ingestion, may suggest that the inhibiting effect is elicited by CCK-8, released in response to glucose absorbed from the PD fluid. The lack of effect of glucose on protein intake in our experiments may also be related to the lowering effect by insulin on the plasma levels of amino acids, which inhibit amino acid-related signals for protein satiety.
Amino acids in peritoneal solutions were introduced with the dual purpose of providing an alternative osmotic agent and giving supplementary protein to patients with protein malnutrition [11] . Since chronic renal failure is associated with amino acids abnormalities that are not fully corrected by CAPD treatment [26] , it has been postulated that dialysis with amino acid solutions may normalize the uptake of amino acids by the central nervous system by inducing less marked stimulation of insulin secretion than with glucose solutions and also by providing an increased supply of branched-chain amino acids [27, 28] .
There is evidence that protein intake, in addition to energy intake, is directly involved in the regulation of feeding behavior and that such regulation is sensitive to the amino acid composition of the protein consumed [29, 30] . The amino acid supply from dietary protein also controls brain metabolism by providing specific amino acids (tryptophan, tyrosine), which are precursors of major neurotransmitters (serotonin, catecholamines). Hence, it has been proposed that amino acids act as significant components of the control mechanism for protein and energy intake by inducing appetite suppression through their effect on neurotransmitter synthesis [31, 32] . Ingestion of a mixed protein, fat and carbohydrate solution or a pure protein solution has been demonstrated to cause a massive increase in plasma levels of CCK-8 [24, 25] . However, clinical studies of the effect of peritoneal dialysis solutions containing amino acids on appetite have given conflicting results, suggesting a decrease [33, 34] , an increase [27, 35] or no change [28, 36] .
Our data demonstrate that PD solutions with amino acids suppressed both sucrose and protein ingestion in a dose-dependent manner. The effect was relatively small (less than 10% inhibition) with the lowest amino acid concentration (11 glliter) , that is, the concentration generally recommended for clinical use [37] .
It has been reported that rats given continuous infusions of energy-containing nutrients reduced their daily food intake, but that the reduction in oral energy intake was only about 40 to 80% of the i.v. energy supply, the variation depending on the type of i.v. nutrition [19, 38] . It was also observed that the oral intake of energy could be further reduced to make it equal to the energy infused, when insulin was coinfused [38] . Intraportal infusion of glucose was also more efficient than i.v. infusion in suppressing oral intake [22] . It should be emphasized that the aforementioned experiments are not directly comparable to ours, since they were performed during several days, while we have studied for the first time the acute effect of nutrients given i.p. on the oral intake of specified nutritional solutions given as a single meal.
We observed that the reduction in oral carbohydrate intake after i.p. injection of PD fluids containing glucose was at each glucose concentration more than twice as high as the total dose of glucose injected i.p. Earlier studies have shown, that after i.p.
injection of glucose-containing PD fluid in rats, only about 50% of the glucose dose is absorbed within the first 45 minutes [39] , that is, within the period when the appetite tests using oral carbohydrate feeding were finished. Hence, the reduction in sucrose intake may in fact have been about four times higher than the effective dose absorbed. Similarly, the amino acid-based solutions reduced the intakes of both protein and sucrose by much larger amounts than the doses of amino acids injected i.p. We speculate that the high efficacy of appetite suppression elicited by the PD solutions is related to the i.p. route of administration, resulting in a rapid uptake of glucose or amino acids in the portal circulation, which in turn resulted in high concentrations in the splanchnic area, with subsequent stimulation of hepatic glucoreceptors and secretion of CCK-8, insulin and other mediators of appetite suppression.
We observed a maximum inhibitory effect of the 38.6 glliter glucose solution on sucrose intake at 30 minutes after the injection. The effect then gradually tapered off, but had not reached the basal level at 180 minutes. In contrast, after intraperitoneal injection of the 31.2 g/liter amino acid solution, the sucrose intake, which was reduced after 30 minutes, continued to decrease over the following 150 minutes. CAPD patients exhibit a peak in blood glucose concentration at 30 to 60 minutes after instillation of glucose-based dialysis fluid, followed by a rapid fall in the concentrations over the next two hours [40] , while after instillation of amino acid-based dialysis fluid, the peak concentrations of plasma amino acids are attained at one to two hours and then remain high over the next one to two hours [36, 41] . Hence, it appears that the patterns of appetite suppression after i.p. injections of glucose or amino acids in rats are similar to the patterns of plasma concentration described for each compound after instillation in CAPD patients. These results accord with the view that inhibiting effects on appetite by i.p. glucose and amino acids, respectively, are mediated by the levels of the circulating compounds.
In conclusion, our results indicate that the inhibition of appetite caused by peritoneal solutions containing glucose or amino acids seems to be specific for each nutritional constituent and not simply an effect of hyperosmolality or large filling volumes.
